Complete Care at Springbrook: Medication Errors - MD
Staff Nurse #6 told inspectors on December 17 that he used the unlabeled Humalog insulin pen because the handwritten room number was "enough to identify the resident." He said he didn't need a proper label.
The violation directly contradicted the facility's own insulin pen policy, which requires clear labeling with the resident name, physician name, date dispensed, type of insulin, amount to be given, frequency, and expiration date.
Inspectors discovered the mislabeled pen on December 16 at 11:49 a.m. while reviewing the West Wing medication cart. The opened and used insulin lispro pen contained none of the required identification information beyond the room number written in marker.
The facility's Director of Nursing acknowledged the serious safety breach during a December 18 interview. She told inspectors that nursing staff should discard any unlabeled insulin pens immediately and notify the pharmacy to reorder properly labeled replacements.
The pharmacy consultant reinforced this guidance in a separate interview. All insulin pens must carry the patient's name, physician name, and date opened, the consultant explained. Once an insulin pen is opened, staff must label it with the opening date.
"Any opened, unlabeled insulin pens should not be used," the pharmacy consultant told inspectors. Instead, the facility should contact the pharmacy and order a new, properly labeled insulin pen.
The medication error exposed residents to potential harm from receiving incorrect insulin doses or medications intended for other patients. Insulin administration requires precise dosing based on individual patient needs, blood sugar levels, and physician orders.
Without proper labeling, nurses cannot verify they are administering the correct medication to the right patient. The handwritten room number system used by Staff Nurse #6 created multiple opportunities for dangerous mix-ups.
Residents could receive insulin prescribed for someone else if room assignments changed or if multiple residents required the same medication. The makeshift labeling also provided no information about dosage, timing, or the prescribing physician's orders.
The facility's comprehensive insulin pen policy, copyrighted in 2025, established clear standards that Staff Nurse #6 ignored. The policy exists specifically to prevent medication errors that could cause severe hypoglycemia, diabetic emergencies, or other serious complications.
Federal regulations require all drugs and biologicals to be labeled according to accepted professional standards. Insulin pens fall under these strict labeling requirements because of their potential for causing significant patient harm when misused.
The inspection occurred in response to a complaint, suggesting someone reported concerns about medication safety practices at the facility. Inspectors focused their review on medication storage and labeling compliance across multiple areas.
They examined three medication carts during their investigation, finding the labeling violation on the West Wing cart. The other medication storage areas apparently met federal requirements for proper drug labeling and storage.
Staff Nurse #6's casual dismissal of labeling requirements revealed a troubling attitude toward medication safety protocols. His belief that a room number constituted adequate identification demonstrated poor understanding of basic pharmacy standards.
The pharmacy consultant's emphatic guidance about discarding unlabeled insulin pens highlighted the serious safety risks involved. Insulin medications require the highest level of precision and identification to prevent potentially life-threatening errors.
Complete Care at Springbrook must now implement corrective measures to ensure all insulin pens receive proper labeling before use. The facility faces ongoing federal oversight to verify compliance with medication safety requirements.
The violation affected multiple aspects of patient safety, from medication identification to proper storage protocols. Federal inspectors classified the harm level as minimal, but the potential for serious injury remained significant given insulin's powerful effects on blood sugar regulation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Complete Care At Springbrook from 2025-12-19 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
COMPLETE CARE AT SPRINGBROOK in SILVER SPRING, MD was cited for violations during a health inspection on December 19, 2025.
Inspectors discovered the mislabeled pen on December 16 at 11:49 a.m.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.